National Utilization and Expenditure Trends of GLP-1 Receptor Agonists and Dual GLP-1/GIP Agonist in Croatia, 2017–2024
<i>Background and Objectives</i>: GLP-1 receptor agonists (GLP-1 RAs; ATC A10BJ) and dual GLP-1/GIP agonist (ATC A10BX16) have expanded rapidly due to strong evidence in type 2 diabetes, obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). Their high acquisition costs and ac...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2025-12-01
|
| Colección: | Medicina |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/1648-9144/61/12/2210 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|